Derry Sheena, Derry Christopher J, Moore R Andrew
Pain Research and Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Cochrane Database Syst Rev. 2013 Jun 26;2013(6):CD010289. doi: 10.1002/14651858.CD010289.pub2.
Combining two different analgesics in fixed doses in a single tablet can provide better pain relief than either drug alone in acute pain. This appears to be broadly true across a range of different drug combinations, in postoperative pain and migraine headache. Fixed-dose combinations of ibuprofen and oxycodone are available, and the drugs may be separately used in combination in some acute pain situations.
To assess the analgesic efficacy and adverse effects of a single oral dose of ibuprofen plus oxycodone for moderate to severe postoperative pain.
We searched the Cochrane Central Register of Controlled Trials, (CENTRAL), on The Cochrane Library, (Issue 4 of 12, 2013), MEDLINE (1950 to 21st May 2013), EMBASE (1974 to 21st May 2013), the Oxford Pain Database, ClinicalTrials.gov, and reference lists of articles.
Randomised, double-blind clinical trials of single dose, oral ibuprofen plus oxycodone compared with placebo or the same dose of ibuprofen alone for acute postoperative pain in adults.
Two review authors independently considered trials for inclusion in the review, assessed quality, and extracted data. We used the area under the pain relief versus time curve to derive the proportion of participants prescribed ibuprofen plus oxycodone, ibuprofen alone, oxycodone alone, or placebo with at least 50% pain relief over six hours, using validated equations. We calculated relative risk (RR) and number needed to treat to benefit (NNT). We used information on use of rescue medication to calculate the proportion of participants requiring rescue medication and the weighted mean of the median time to use. We also collected information on adverse events.
Searches identified three studies involving 1202 participants. All examined the same dose combination. Included studies provided data from 603 participants for the comparison of ibuprofen 400 mg + oxycodone 5 mg with placebo, 717 participants for the comparison of ibuprofen 400 mg + oxycodone 5 mg with ibuprofen 400 mg alone, and 471 participants for the comparison of ibuprofen 400 mg + oxycodone 5 mg with oxycodone 5 mg alone.The proportion of participants achieving at least 50% pain relief over 6 hours was 60% with ibuprofen 400 mg + oxycodone 5 mg and 17% with placebo, giving an NNT of 2.3 (2.0 to 2.8). For ibuprofen 400 mg alone the proportion was 50%, producing no significant difference between ibuprofen 400 mg + oxycodone 5 mg and ibuprofen 400 mg alone. For oxycodone 5 mg alone the proportion was 23%, giving an NNT for ibuprofen 400 mg + oxycodone 5 mg compared with oxycodone alone of 2.9 (2.3 to 4.0).Ibuprofen + oxycodone resulted in longer times to remedication than with placebo. The median time to use of rescue medication was more than 5 hours for ibuprofen 400 mg + oxycodone 5 mg, and 2.3 hours or less with placebo. Fewer participants needed rescue medication with ibuprofen + oxycodone combination than with placebo or ibuprofen alone. The proportion was 40% with ibuprofen 400 mg + oxycodone 5 mg, 83% with placebo, 53% with ibuprofen alone, and 83% with oxycodone alone, giving NNT to prevent one patient needing rescue medication of 2.4 (2.0 to 2.9), 11 (6.1 to 56), and 2.6 (2.1 to 3.4) for comparisons of ibuprofen 400 mg + oxycodone 5 mg with placebo, ibuprofen alone, and oxycodone alone, respectively.The proportion of participants experiencing one or more adverse events was 25% with ibuprofen 400 mg + oxycodone 5 mg, 25% with placebo, 26% with ibuprofen alone, and 35% with oxycodone alone; they were not significantly different. Serious adverse events were reported only after abdominal surgery 6/169 with the combination, 1/175 with ibuprofen alone, 3/52 with oxycodone alone, and 1/60 with placebo. Withdrawals for reasons other than lack of efficacy were fewer than 5% and balanced across treatment arms.
AUTHORS' CONCLUSIONS: The combination of ibuprofen 400mg + oxycodone 5mg provided analgesia for longer than oxycodone alone, but not ibuprofen alone (at the same dose). There was also a smaller chance of needing additional analgesia over about eight hours, and with no greater chance of experiencing an adverse event.
在一片药片中固定剂量联合使用两种不同的镇痛药,相较于单独使用其中任何一种药物,能在急性疼痛中提供更好的疼痛缓解效果。在术后疼痛和偏头痛等一系列不同的药物组合中,这一点似乎普遍成立。布洛芬和羟考酮有固定剂量组合剂型,并且在某些急性疼痛情况下这两种药物也可分开联合使用。
评估单剂量口服布洛芬加羟考酮用于中度至重度术后疼痛的镇痛效果及不良反应。
我们检索了Cochrane对照试验中心注册库(CENTRAL),该库收录于《Cochrane图书馆》(2013年第12期第4卷)、MEDLINE(1950年至2013年5月21日)、EMBASE(1974年至2013年5月21日)、牛津疼痛数据库、ClinicalTrials.gov以及文章的参考文献列表。
将单剂量口服布洛芬加羟考酮与安慰剂或相同剂量的布洛芬单独使用,用于成人急性术后疼痛的随机、双盲临床试验。
两名综述作者独立考虑纳入综述的试验,评估质量并提取数据。我们使用疼痛缓解程度与时间曲线下的面积,通过验证方程得出在6小时内疼痛缓解至少50%的服用布洛芬加羟考酮、单独服用布洛芬、单独服用羟考酮或安慰剂的参与者比例。我们计算了相对危险度(RR)和需治疗获益人数(NNT)。我们利用急救药物使用信息计算需要急救药物的参与者比例以及使用急救药物的中位时间加权均值。我们还收集了不良事件的信息。
检索到三项涉及1202名参与者的研究。所有研究均考察相同的剂量组合。纳入研究提供了603名参与者的数据用于布洛芬400mg + 羟考酮5mg与安慰剂的比较,717名参与者的数据用于布洛芬400mg + 羟考酮5mg与单独使用布洛芬400mg的比较,以及471名参与者的数据用于布洛芬400mg + 羟考酮5mg与单独使用羟考酮5mg的比较。服用布洛芬400mg + 羟考酮5mg的参与者在6小时内疼痛缓解至少50%的比例为60%,服用安慰剂的比例为17%,NNT为2.3(2.0至2.8)。单独使用布洛芬400mg时该比例为50%,布洛芬400mg + 羟考酮5mg与单独使用布洛芬400mg之间无显著差异。单独使用羟考酮5mg时该比例为23%,布洛芬400mg + 羟考酮5mg与单独使用羟考酮相比的NNT为2.9(2.3至4.0)。
布洛芬加羟考酮导致再次用药的时间比安慰剂更长。布洛芬400mg +羟考酮5mg使用急救药物的中位时间超过5小时,而安慰剂组为2.3小时或更短。与安慰剂或单独使用布洛芬相比,使用布洛芬加羟考酮组合的参与者需要急救药物的更少。布洛芬400mg + 羟考酮5mg组的比例为40%,安慰剂组为83%,单独使用布洛芬组为53%,单独使用羟考酮组为83%,布洛芬400mg + 羟考酮5mg与安慰剂、单独使用布洛芬、单独使用羟考酮比较时预防一名患者需要急救药物的NNT分别为2.4(2.0至2.9)、11(6.1至56)和2.6(2.1至3.4)。
经历一种或多种不良事件的参与者比例,布洛芬400mg + 羟考酮5mg组为25%,安慰剂组为25%,单独使用布洛芬组为26%,单独使用羟考酮组为35%;差异无统计学意义。仅在腹部手术后报告了严重不良事件,联合用药组169例中有6例,单独使用布洛芬组175例中有1例,单独使用羟考酮组52例中有3例,安慰剂组60例中有1例。因缺乏疗效以外的原因退出的比例低于5%,且各治疗组间均衡。
布洛芬400mg + 羟考酮5mg组合提供的镇痛时间比单独使用羟考酮长,但不比单独使用布洛芬(相同剂量)长。在约8小时内需要额外镇痛的可能性也较小,且发生不良事件的可能性没有增加。